Aditxt is a biotech company. Co. is developing and commercializing technologies with a focus on monitoring and modulating the immune system. Co.'s portfolio includes the following programs: Adimune™, which are immune modulation technologies designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies; and AditxtScore™, which are immune monitoring technologies designed to provide a personalized comprehensive profile of the immune system.